Add time:08/02/2019         Source:sciencedirect.com

BackgroundAn increased incidence of prostate cancer was observed in Parkinson's disease (PD) patients treated with Entacapone (cas 116314-67-1) during a pre-approval randomized clinical trial; the relation has not been robustly investigated in the U.S. ambulatory setting.

We also recommend Trading Suppliers and Manufacturers of Entacapone (cas 116314-67-1). Pls Click Website Link as below: cas 116314-67-1 suppliers